Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Lactobacillus plantarum 299v

What does the research say about Lactobacillus plantarum 299v?

2 health outcomes synthesised

Lactobacillus plantarum 299v has been studied for two health outcomes: irritable bowel syndrome (IBS) symptoms and quality of life. The strongest evidence supports its role in improving IBS symptoms, based on 3 studies including a meta-analysis of 2,643 patients, showing a moderate effect. No consistent dosing or form was reported across studies, and the research primarily involves IBS patients and cancer patients receiving enteral nutrition.

Strongest evidence: The most robust research supports Lactobacillus plantarum 299v for improving irritable bowel syndrome (IBS) symptoms. All 3 studies (including a meta-analysis of 2,643 patients and an observational study of 221 patients) reported beneficial effects with a moderate effect size. The evidence strength is rated as moderate, though no consistent dose or form data were available across studies. One study noted benefits over 12 weeks of treatment.

Mixed or weaker evidence: Evidence for improved quality of life is low. All 3 studies reported beneficial effects, but only 1 reached statistical significance (an observational study). The two RCTs (both in cancer patients) had small sample sizes (21 and not reported) and one found no significant difference versus placebo. Effect sizes ranged from small to moderate.

Effective dose patterns: No cross-cutting dose insights are available because neither synthesis reported consistent dosage or form data. This limits practical interpretation of the findings.

Population insights: The primary populations studied are patients with IBS and cancer patients receiving home enteral nutrition. In both groups, improvements were observed, but the evidence base for IBS is stronger and more consistent. No specific subpopulations (e.g., elderly, deficient groups) were identified.

Notable caveats: Both outcomes are supported by only 3 studies each, and one of the IBS studies is a low-evidence review. The observational studies may be subject to confounding, and the lack of dosing and form information makes it difficult to compare results or extrapolate to real-world use. Duration of treatment varied, with only one IBS study reporting a consistent 12-week period.

Frequently asked

  • What is Lactobacillus plantarum 299v good for according to research?
    Research has examined Lactobacillus plantarum 299v for two health outcomes: improving irritable bowel syndrome (IBS) symptoms and improving quality of life. The strongest evidence supports its use for IBS symptoms, based on 3 studies with moderate evidence strength and a moderate effect size. Evidence for quality of life is weaker, with only 1 of 3 studies reaching statistical significance.
  • What dose of Lactobacillus plantarum 299v is typically used in studies?
    The available research syntheses did not extract consistent dosing or form data for Lactobacillus plantarum 299v. Therefore, no typical dose can be identified from the reviewed studies. Future research with standardized reporting is needed.
  • Who benefits most from Lactobacillus plantarum 299v?
    The studied populations include patients with IBS and cancer patients receiving home enteral nutrition. Both groups showed benefits, but the evidence is stronger and more consistent for IBS patients. No specific demographic or health-status subgroups (e.g., based on age or deficiency) were identified in the research.
  • Are there caveats or limitations in the research on Lactobacillus plantarum 299v?
    Yes. Each outcome is supported by only 3 studies, and one of the IBS studies is a low-evidence review. Observational studies may be subject to confounding, and the lack of dose/form data limits practical guidance. For quality of life, two RCTs had small sample sizes and one did not show significant improvement versus placebo.
  • Does Lactobacillus plantarum 299v help with IBS symptoms?
    All 3 studies on IBS symptoms reported beneficial effects with a moderate effect size, including a meta-analysis of 2,643 patients that showed improvement in global symptoms and quality of life. However, the evidence is considered moderate due to limitations such as one low-evidence review and inconsistent reporting of dosing and treatment duration.

  • Vegan Ideal Bowel Support

    By Jarrow Formulas

    4.6 (2.6K reviews)
    Out of Stock
    Best Price Guarantee
    Prices from Different Sellers
    Prices from Different Sellers
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $21.37
    		In
    Vitacost
    $19.69
    		In
    Vitamin Shoppe
    $-
    		Out

  • Pro-IBS Support

    By Hyperbiotics

    4 (13 reviews)
    Out of Stock
    Best Price Guarantee
    Prices from Different Sellers
    Prices from Different Sellers
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $32.99
    		In
    Vitacost
    $-
    		Out
    Vitamin Shoppe
    $-
    		Out

  • UltraFlora

    By Metagenics

    4 (1 reviews)
    Out of Stock
    Best Price Guarantee
    Prices from Different Sellers
    Prices from Different Sellers
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $62.43
    		In
    Vitacost
    $-
    		Out
    Vitamin Shoppe
    $-
    		Out
Back to top